Thu, Jul 24, 2014, 2:12 PM EDT - U.S. Markets close in 1 hr 48 mins

Recent

% | $
Click the to save as a favorite.

ModusLink Global Solutions, Inc. Message Board

charly_22003 1 post  |  Last Activity: Jul 16, 2014 4:31 PM Member since: May 13, 2005
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • COLUMBIA, Md.--(BUSINESS WIRE)-- Osiris Therapeutics, Inc. (OSIR), announced the addition of several new sizes to the Grafix® product line. Grafix, a cryopreserved placental membrane, is regulated under 21 CFR 1271, part 361, Human Cells, Tissues and Cellular Tissue-Products (HCT/Ps) as a wound cover. Like other HCT/Ps, Grafix can be manufactured in multiple sizes, giving health care providers the ability to optimally match Grafix to the wound size, reduce overall treatment costs and eliminate concerns regarding product waste. Grafix is now available in five convenient sizes and is very well-positioned to remain a cost effective option within the Centers for Medicare & Medicaid Services bundled payment system.

    In addition to the launch of multiple new sizes, Osiris is introducing an innovative delivery system. The new design reduces thaw time, increases product maneuverability and eases the overall application of Grafix to the wound bed.

    “Our objective is to deliver the highest quality wound product to providers and their patients suffering from chronic wounds. We continue to make tremendous strides with Grafix and look forward to broadening access to more patients now that our pivotal 302 trial has been accepted for publication,” said Lode Debrabandere, Ph.D., President and Chief Executive Officer of Osiris.

    About Grafix

    Grafix is a cryopreserved placental membrane for acute and chronic wounds. It is a flexible, conforming membrane that is applied directly at the site of the wound. Grafix is produced by Osiris’ BioSmartTM Intelligent Tissue Processing which maintains the integrity of the extracellular matrix, growth factors, and endogenous fibroblasts, epithelial cells and mesenchymal stem cells of the native tissue.

MLNK
3.75+0.01(+0.27%)2:07 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.